Creon

Product manufactured by Abbvie Inc.

Application Nr Approved Date Route Status External Links
BLA020725 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Creon ® Is Indicated For The Treatment Of Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Other Conditions. Creon Is A Combination Of Porcine-Derived Lipases, Proteases, And Amylases Indicated For The Treatment Of Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Other Conditions. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 3 Total)

Comments